Jupiter Neurosciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell JUNS and other ETFs, options, and stocks.

About JUNS

Jupiter Neurosciences, Inc. is a clinical-stage pharmaceutical company engaged in treating neuroinflammation with a current focus on CNS disorders and rare diseases. The firm offers JOTROL, an enhanced orally administered resveratrol formulation, designed to deliver therapeutically relevant, safe levels of resveratrol. 

CEO
Christer Rosén
CEOChrister Rosén
Employees
5
Employees5
Headquarters
Jupiter, Florida
HeadquartersJupiter, Florida
Founded
2015
Founded2015
Employees
5
Employees5

JUNS Key Statistics

Market cap
9.57M
Market cap9.57M
Price-Earnings ratio
-0.98
Price-Earnings ratio-0.98
Dividend yield
Dividend yield
Average volume
35.53M
Average volume35.53M
High today
$0.2753
High today$0.2753
Low today
$0.2494
Low today$0.2494
Open price
$0.266
Open price$0.266
Volume
2.48M
Volume2.48M
52 Week high
$3.33
52 Week high$3.33
52 Week low
$0.1721
52 Week low$0.1721

Stock Snapshot

The current Jupiter Neurosciences(JUNS) stock price is $0.26, with a market capitalization of 9.57M. The stock trades at a price-to-earnings (P/E) ratio of -0.98.

During the trading session on 2026-06-02, Jupiter Neurosciences(JUNS) shares reached a daily high of $0.28 and a low of $0.25. At a current price of $0.26, the stock is +4.8% higher than the low and still -5.1% under the high.

Trading activity shows a volume of 2.48M, compared to an average daily volume of 35.53M.

The stock's 52-week range extends from a low of $0.17 to a high of $3.33.

The stock's 52-week range extends from a low of $0.17 to a high of $3.33.

People also own

Based on the portfolios of people who own JUNS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.